chr11-72822214-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033388.2(ATG16L2):āc.563C>Gā(p.Ala188Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,504,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033388.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATG16L2 | NM_033388.2 | c.563C>G | p.Ala188Gly | missense_variant | 5/18 | ENST00000321297.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATG16L2 | ENST00000321297.10 | c.563C>G | p.Ala188Gly | missense_variant | 5/18 | 1 | NM_033388.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152062Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000400 AC: 4AN: 99928Hom.: 0 AF XY: 0.0000354 AC XY: 2AN XY: 56526
GnomAD4 exome AF: 0.000152 AC: 205AN: 1352798Hom.: 0 Cov.: 33 AF XY: 0.000141 AC XY: 94AN XY: 667442
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152062Hom.: 0 Cov.: 33 AF XY: 0.0000943 AC XY: 7AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2022 | The c.563C>G (p.A188G) alteration is located in exon 5 (coding exon 5) of the ATG16L2 gene. This alteration results from a C to G substitution at nucleotide position 563, causing the alanine (A) at amino acid position 188 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at